drugs Flashcards
C/I for BZD
pulmonary insufficiency, marked neuromusclar respiratory weakness, sleep apnoea synd, unstable myasthenia gravis
BZD- paradoxical effect
increase in hostility, agression
Dexafetamine and lisdexfetamine s/e
tics and tourette syndrome - stop if tics happen
monitor children’s growth, weight and height
growth restriction in prolonged treatment
antipsychotics c/i
CNS depression, coma, hypothyroidism, phaeochromocytoma
antipsychotics cautions
DM, blood dyscrasia, depression, seizures, CVD, DM ( raise BG), jaundice, MG, PD ( may be exacerbated), photosensitisation, prostatic hypertrophy, severe resp, angle closure glaucoma
chlorpromazine i/n food& lifestyle
smoking, dose adjustiment
why will chlorpromazine ( antipsychotics) exacerbate PD
acute dystonic reaction, facial and skeletal muscle spasm and oculogyrics crises
phenothiazines are indicated for? and is it toxic to liver or kidney
antipsychotics ( 1st Gen), hepatotoxic
why all antipsychotics users should avoid direct sunlight
photosensitisation occur with high dose
monitoring for antipsychotics
prolactinaemia - prolactin conc 6M, Y
what is the biggest C/I of pimozide ? what is the indication
schizophrenia, antipsychotics
QT prolongation
monitoring of pimozide?
ECG annually
drug i/n with pimozide
other antipsychotics, TCA, antimalarial, some antihistamines ( electrolyte disturbances )
risk of QT prolongation drugs
what antipsychotics is used for resistant schizophrenia
clozapine
what GI cautions with clozapine
risk intestinal obstuction due to antimuscarinic effect in GI
cautions when use with other constipating medication (antimuscarinic )
or those with a history of colonic disease or lower abdominal surgery
s/e of clozapine
leucocytopenia, blood dsycrasia
children’s endocrine, growth restriction
myocarditis and cardiomyopathy
hypersalivation ( treat with hyoscine)
lithium toxicity signs
REVeNGe renal dist Extrapyramidal Visual dist cNs disturba GI dist (hyponatraemia)
> 2mmol/ L severe OD- seizures, cardiac arrhythmia, BP changes, circulatory failure, coma and sudden death
how should lithium be monitored ? and what are the ranges
0.4-1mmol/l ( post dose 12 hrs)
0.8-1mmol/l for acute mania or who have previously relapsed or sub-syndromal symptx
weekly at initiation and after each dose change until conc is stable, then 3 montly,
additional measurement if ill or significant change in sodium and fluid intake
lithium S/E and I/N
- renal ( polyuria, polydispisia)
- thyoid - hypothyroidism - ( weigh loss, fatigue)
- Neurotoxicity
- serotonin syndrome
- QT prolongation
- seizures threshold
- benign intracranial HTN ( headache, visual disturbances)
- hyponatramia (predispose to Li toxicity)
- extrapyramidal
- mild cognitive and memory impairment
- teratogenic
(brand specific )
OTC i/n for lithium
ibuprofen, soluble analgesics ( high salt content), Na+ containing antacids